Free Online CME

Disease Management Clinical Decisions



The Immunologic Basis of Wellness: How personal behavior influences rheumatoid arthritis

Print this Content

Release date: June 24, 2019
Expiration date: June 24, 2022

Estimated Time of Completion: 45 minutes

Description

Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.

Learning Objectives

After completing this case the reader should be able to:

  • Describe epidemiology of personal behavioral choices as risk factors for rheumatoid arthritis.
  • Correlate the immunopathogenesis of rheumatoid arthritis with the immunologic effects of common wellness behaviors.
  • Incorporate principles of wellness education in the clinical practice of rheumatology.

Target Audience

Directed to primary care physicians including family practitioners and internists.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Anthony Fernandez, MD, PhD
Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Co-Medical Director, Center for Continuing Education
Cleveland Clinic
Cleveland, OH

Faculty

Cassandra Calabrese, DO
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:

Cassandra Calabrese, DO
  GlaxoSmithKline Advisory Board
  Sanofi/Regeneron Teaching and Speaking
Leonard Calabrese, DO
  Abbvie Pharmaceuticals Consulting
Teaching and Speaking
  BMS Consulting
Teaching and Speaking
  Crescendo Teaching and Speaking
  GSK Consulting
  Genentech/Roche Consulting
Teaching and Speaking
  Horizon Pharma Consulting
  Janssen Consulting
Teaching and Speaking
  Novartis Consulting
Teaching and Speaking
  Pfizer Consulting
  Regeneron Consulting
  Sanofi Aventis Consulting
  UCB Consulting
Anthony Fernandez, MD, PhD
  Novartis Consulting; Independent contractor (including contracted research); Teaching and Speaking
  Abbvie Pharmaceuticals Consulting; Teaching and Speaking
  Celgene Corporation Consulting
  Mallinckrodt Inc. Independent contractor (including contracted research);
Teaching and Speaking
  Pfizer, Inc. Independent contractor (including contracted research)
  Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education.

 

RJ Fasenmyer Center for Clinical Immunology has a web-based, e-coached wellness program for practitioners caring for patients with an IMID. The program is evidence-based, designed to complement therapies for IMIDs, and will uniquely convey a message to patients that their personal behaviors can affect the driver of their illness: their immune system. This is a message of empowerment, a technique known to enhance behavioral change.

Learn more at www.ClevelandClinicWellness.com/Immune